Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Asymptomatic progressive multifocal leukoencephalopathy during natalizumab therapy with treatment.
Multiple sclerosis and related disorders: evolving pathophysiologic insights.
TNFRSF1A in multiple sclerosis: A tale of soluble receptors and signaling cascades.
Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.
The experiences of support persons of people newly diagnosed with multiple sclerosis: an interpretative phenomenological study.
Heat shock protein 70 (Hsp70) interacts with the Notch1 intracellular domain and contributes to the activity of Notch signaling in myelin-reactive CD4 T cells.
A pilot study to improve adherence among MS patients who discontinue treatment against medical advice.
Use of health services in people with multiple sclerosis with and without depressive symptoms: a two-year prospective study.
Resveratrol Exacerbates Both Autoimmune and Viral Models of Multiple Sclerosis.
Fumaric Acid Esters Stimulate Astrocytic VEGF Expression through HIF-1α and Nrf2.
Behcet's disease.
Atypical presentation of Charcot-Marie-Tooth disease 1A: A case report.
Anti-annexin antibodies, cholesterol levels and disability in multiple sclerosis.
[Epidemiology of multiple sclerosis].
Can hand dexterity predict the disability status of patients with multiple sclerosis?
Trigeminal autonomic cephalalgia as a presenting feature of Neuromyelitis Optica: "A rare combination of two uncommon disorders".
Treatment of Trigeminal Neuralgia Associated with Multiple Sclerosis.
"Her illness is a project we can work on together": developing a collaborative family-centered intervention model for newly diagnosed multiple sclerosis.
HDAC inhibitors mitigate ischemia-induced oligodendrocyte damage: potential roles of oligodendrogenesis, VEGF, and anti-inflammation.
5-Aminoisoquinolin-1-one (5-AIQ), a Water-Soluble Inhibitor of the Poly¬(ADP Ribose)¬Polymerases (PARPs).
Olfactory Ensheathing Cell Transplantation after a Complete Spinal Cord Transection Mediates Neuroprotective and Immunomodulatory Mechanisms to Facilitate Regeneration.
12 Weeks of Combined Endurance and Resistance Training Reduces Innate Markers of Inflammation in a Randomized Controlled Clinical Trial in Patients with Multiple Sclerosis.
[Actual medical care situation and therapeutic needs in multiple sclerosis : Impact of the Pharmaceutical Market Restructuring Act (AMNOG)].
Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome.
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.

Pages